PCSC logo

PERCEPTIVE CAPITAL SOLUTIONS

PCSCNASDAQ
US Equity
$11.95β–² $0.00 (+0.00%)
Market closed Β· at close
1hβ€”
24hβ–² 0.0%
7dβ–Ό 0.6%
14dβ–Ό 0.6%
30dβ–² 8.6%
1yβ–² 13.1%
🏦Market Cap
$291.11B
Large Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
55
Weak

Trading Snapshot

Day Range
$11.82 – $12.05
52-Week Range
$9.95 – $14.47
Volume
$3.49B
Avg Volume
$3.56B
Shares Outstanding
β€”
Next Earnings
Sep 22, 2026

Fundamentals Snapshot

Annual Revenue
$44.11B
Last Q Revenue
$826,382
P/E Ratio
1150.1
P/S Ratio
β€”
EPS (TTM)
$0.01
Dividend Yield
β€”

Why Investors Own PCSC

  • βœ“High-growth profile β€” revenue up +4.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 48% gross margin and 25% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$44.11Bβ–² +0.6% YoY
Gross Margin (TTM)
48.2%β–² +2.9% YoY
Operating Income (TTM)
$14.16Bβ–² +0.6% YoY
Free Cash Flow (TTM)
$11.07Bβ–² +0.6% YoY

About PERCEPTIVE CAPITAL SOLUTIONS

Currently, Perceptive Capital Solutions Corp possesses no significant active operations. Its principal objective is to execute a strategic business combinationβ€”such as a merger, share swap, asset procurement, equity acquisition, or corporate restructuringβ€”with one or more enterprises or entities engaged in the life sciences and medical technology sectors. These prospective partners are sought exclusively within North America or Europe. The company was established in 2024, with its corporate base located in New York, New York.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
55/100

Analyst Price Target

β“˜
Average Target
$12.70
β–² +6.2% Upside
High Target$15.71
Low Target$11.34
Based on 15 analysts

Latest News & Updates